Rachael Mccool
Innovation Way
York, ENG, United Kingdom
York, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Immunoglobulin replacement therapy in primary immunodeficiency disorders: Pragmatic review and evidence mapping.
Journal: The journal of allergy and clinical immunology. Global
Published: September 08, 2025
Nirsevimab for preventing respiratory syncytial virus lower respiratory tract infections in infants: a systematic review and meta-analysis.
Journal: Frontiers in public health
Published: June 04, 2025
A scoping review of the evidence base for the performance of leading indicators for improving safety outcomes: Available evidence, implications for practice and future directions.
Journal: Journal of safety research
Published: March 20, 2025
Opportunities for and Challenges of Conducting Indirect Treatment Comparisons and Meta-Analyses for Vaccines in Post-EU HTA Regulation Era.
Journal: Journal of market access & health policy
Published: December 19, 2024
Response to 'Why the lack of enthusiasm for renal denervation?'
Journal: Journal of hypertension
Published: October 29, 2024
A systematic review of bone graft products used in lumbar interbody fusion procedures for degenerative disc disease.
Journal: North American Spine Society journal
Published: August 15, 2024
Single-arm interventional versus observational studies for assessing efficacy: A meta-epidemiological study.
Journal: Cochrane evidence synthesis and methods
Published: June 11, 2024
Literature review and meta-analysis of natalizumab therapy for the treatment of highly active relapsing remitting multiple sclerosis in the 'suboptimal therapy' patient population.
Journal: Journal of the neurological sciences
Published: April 29, 2024
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia.
Journal: International clinical psychopharmacology
Published: August 02, 2022
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression.
Journal: Frontiers in oncology
Published: March 05, 2021
Last Updated: 09/26/2026